Peter Schmid

Peter Schmid

FRCP, MD, PhD
Barts Cancer Institute, London, UK

Peter Schmidt, FRCP, MD, PhD, studied medicine in Munich and Aberdeen. He was awarded scholarships by the German National Academic Foundation, the German Academic Exchange Service and the Hanns-Seidel-Foundation. He subsequently completed his specialist training in internal medicine, medical oncology and haematology in Berlin. He undertook an MD in Clinical Chemistry at the Technical University Munich and a PhD in Medical Oncology at the Charité University in Berlin. Prof. Peter Schmid moved to the UK in 2005 to take on roles as Senior Clinical Lecturer and Director of the Hammersmith Early Clinical Trials Unit at Imperial College London, and subsequently as Foundation Chair in Cancer Medicine at the University of Sussex.

He focuses his clinical practice on breast cancer, lung cancer and cancer immune therapy. He led the formation of the Cancer Immune Therapy group at Barts Hospital which have become internationally-leading in this rapidly developing field. He has an international reputation for cancer immunotherapy and leads a number of global immunotherapy trials.